Kazia Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-18.82	-20.7	-26.78	-20.47	-25.01	-8.42
Depreciation & Amortization	-	0.93	1.87	1.87	1.87	1.27
Stock-Based Compensation	6.95	0.65	6.49	1.16	1.68	0.64
Other Adjustments	-0.05	7.17	-1.43	-2.32	-2.52	2.51
Change in Receivables	-0.33	3.8	0.01	3.45	-0.01	-5.03
Changes in Accounts Payable	-0.7	-4.95	10.74	0.57	-0.53	1.01
Changes in Accrued Expenses	0.03	0.03	-0.35	0.26	0.2	0.09
Changes in Other Operating Activities	-31.02	-13.49	-9.71	0.32	1.56	-1.18
Operating Cash Flow	-19.16	-13.35	-9.59	-15.16	-22.76	-9.11
Other Investing Activities	-	-	-	-	-2.37	-
Investing Cash Flow	-	-	-	-	-2.37	-
Long-Term Debt Issued	-	-	0.78	-	-	-
Long-Term Debt Repaid	0.56	-	-0.37	-	-	-
Net Long-Term Debt Issued (Repaid)	0.56	-	0.4	-	-	-
Issuance of Common Stock	80.56	15.98	5.58	12.97	3.73	28.11
Net Common Stock Issued (Repurchased)	80.56	15.98	5.58	12.97	3.73	28.11
Financing Cash Flow	119.17	15.98	5.99	12.97	3.73	28.11
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1.1	-0.02	0.01	0.06	1.18	-0.18
Net Cash Flow	100.01	2.7	-3.6	-2.18	-21.4	19
Free Cash Flow	-19.16	-13.35	-9.59	-15.16	-22.76	-9.11
FCF Margin	-2163.25%	-729.96%	-386.54%	-1515600.00%	-91048.00%	-60.00%
Free Cash Flow Per Share	-8.59	-12.18	-18.19	-41.12	-85.92	-38.71
Levered Free Cash Flow	-45.61	-38.18	-23.83	-17.44	-21.91	-7.24
Unlevered Free Cash Flow	-50.45	-42.93	-25.63	-20.81	-21.91	-4.84

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q